Patent ID: 11939340
Assignee: PRELUDE THERAPEUTICS INCORPORATED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 11:
12. The compound of claim 1, that is a compound of formula IX, formula X, formula XI, formula XII, formula XIII, formula XIV, formula XV, formula XVI, formula XVII or formula XVIII:, , or a pharmaceutically acceptable salt or solvate or N-oxide thereof; wherein
E is bond, C(Ra)2, NRa, —O—, —S—, SO, SO2, SO2NRa, —C(═O)NRa—, NRaC(═O)NRa, or NRaS(O)2NRa;
R4 is H, D, Me, or haloalkyl; and
each q is independently 0, 1, 2 or 3.